Intuitive Surgical, Inc.

312,76 USD 1,94 (+0,62%)
Bid 312,76 USD
Ask 313,73 USD

Premiumpartner

Firmenbeschreibung

Intuitive Surgical, Inc. ist ein US-amerikanisches Medizintechnikunternehmen. Der Konzern gehört zu den führenden Anbietern von Robotersystemen, die innerhalb der minimal invasiven Chirurgie (MIS) eingesetzt werden. Kernprodukt des Unternehmens ist das sogenannte da Vinci®-System. Das eigens von Intuitive Surgical entwickelte Produkt wird sowohl bei Eingriffen im Thoraxbereich oder am Herzen als auch in der Urologie und Gynäkologie verwendet. Das System besteht aus einer Operationskonsole, einem hochauflösenden Bildschirmsystem mit 3D-Virtualisierung sowie patentierten Instrumenten. So bietet die Apparatur dem Benutzer die Möglichkeit, selbst schwierige Eingriffe und Operationen bei nur geringer Inzision noch präziser durchführen zu können. Zu den Kunden des Unternehmens gehören in erster Linie Krankenhäuser, außerdem wird das da Vinci®-System auch innerhalb des Militärs eingesetzt. Unter dem Dach der Intuitive Surgical, Inc. entwickeln und produzieren zahlreiche Tochterfirmen verschiedenartige Produkte, die innerhalb der operativen Medizin gebraucht werden. Die Tochtergesellschaften vertreiben die jeweiligen Produkte unter eigenem Markennamen. Hierzu gehören unter anderem: EndoWrist, da Vinci®-Si oder Single-Site. Außerdem arbeitet der Konzern mit verschiedenen anderen Unternehmen und Forschungszentren zusammen, um den technischen Standard seiner Produkte verbessern zu können. Das Unternehmen kooperiert mit dem Massachusetts Institute of Technology (MIT), Power Medical Interventions, InTouch Health und der John Hopkins Universität.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Freefloat (77.9%),The Vanguard Group, Inc. (7.8%),BlackRock, Inc. (7.4%),T. Rowe Price Associates, Inc. (6.9%)
sharesOutstanding: 350398068.0000
ceo: Dr. Gary S. Guthart
board: Jamie Samath, Bob DeSantis, Craig Child, Dave J. Rosa, Dr. Brian Miller, Dr. Chris Carlson, Gillian Duncan, Glenn Vavoso, Henry Charlton, Julian Nikolchec, Kara Andersen Reiter, Lesly Marban, Mark Johnson, Marshall L. Mohr, Myriam J. Curet
supervisoryBoard: Dr. Craig H. Barratt, Amal M. Johnson, Amy L. Ladd, M.D., Dr. Alan J. Levy, Dr. Don Kania, Dr. Gary S. Guthart, Jami Dover Nachtsheim, Joseph C. Beery, Keith R. Leonard, Jr., Mark J. Rubash, Monica P. Reed, M.D.
countryID: 20
freeFloat: 77.9000
faceValue: 0.0010
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Medizintechnische Produkte
industryName: Gesundheitswesen
subsectorName: Hochentwickelte medizinische Geräte
country: USA
countryName: USA

Kontakt

phone: +1-408-523-2161
email: investor.relations@intusurg.com
irWebSite: goo.gl/W5uRbZ

Adresse

street: 1020 Kifer Road, Building 101
city: Sunnyvale, California 94086-5304, USA
phone: +1-408-523-2100
fax: +1-408-523-1390
webSite: www.intuitivesurgical.com

Finanzen (kurz)

year: 2020 cash: 1622.6000
balanceSheetTotal: 11168.9000 liabilities: 1409.8000
totalShareholdersEquity: 9759.1000 sales: 4358.4000
investment: 0.0000 incomeBeforeTaxes: 1207.0000
netIncome: 1060.6000 cashFlow: 455.9000
employees: 8081 currencyID: 4
units: 1000000 currency: USD
year: 2021 cash: 1290.9000
balanceSheetTotal: 13555.0000 liabilities: 1603.5000
totalShareholdersEquity: 11951.5000 sales: 5710.1000
investment: 0.0000 incomeBeforeTaxes: 1890.3000
netIncome: 1704.6000 cashFlow: -332.5000
employees: 9793 currencyID: 4
units: 1000000 currency: USD
year: 2022 cash: 1581.2000
balanceSheetTotal: 12974.0000 liabilities: 1861.4000
totalShareholdersEquity: 11112.6000 sales: 6222.2000
incomeBeforeTaxes: 1606.8000 netIncome: 1322.3000
cashFlow: 294.7000 currencyID: 4
units: 1000000 currency: USD

Finanzen (kurz)

year: 2020
cash: 1622.6000
balanceSheetTotal: 11168.9000
liabilities: 1409.8000
totalShareholdersEquity: 9759.1000
sales: 4358.4000
investment: 0.0000
incomeBeforeTaxes: 1207.0000
netIncome: 1060.6000
cashFlow: 455.9000
employees: 8081
currencyID: 4
units: 1000000
currency: USD
year: 2021
cash: 1290.9000
balanceSheetTotal: 13555.0000
liabilities: 1603.5000
totalShareholdersEquity: 11951.5000
sales: 5710.1000
investment: 0.0000
incomeBeforeTaxes: 1890.3000
netIncome: 1704.6000
cashFlow: -332.5000
employees: 9793
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 1581.2000
balanceSheetTotal: 12974.0000
liabilities: 1861.4000
totalShareholdersEquity: 11112.6000
sales: 6222.2000
incomeBeforeTaxes: 1606.8000
netIncome: 1322.3000
cashFlow: 294.7000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2021 units: 1000000
balanceSheetTotal: 13555.0000 cash: 1290.9000
currentAssets: 5844.9000 fixedAssets: 7710.1000
liabilities: 1149.8000 nonCurrentLiabilities: 453.7000
totalLiabilitiesEquity: 13555.0000 totalShareholdersEquity: 11951.5000
employees: 9793 property: 1876.4000
longTermInvestments: 4415.5000 inventories: 587.1000
accountsReceivable: 782.7000 accountsPayable: 121.2000
liabilitiesTotal: 1603.5000 minorityInterests: 50.4000
sales: 5710.1000 depreciation: 310.2000
netIncome: 1704.6000 operatingResult: 1821.0000
incomeInterest: 69.3000 investments: 671.0000
incomeTaxes: 162.2000 costGoodsSold: 1751.6000
grossProfit: 3958.5000 minorityInterestsProfit: 23.5000
revenuePerEmployee: 583079.7508 cashFlow: 2089.4000
cashFlowInvesting: -2461.5000 cashFlowFinancing: 43.0000
cashFlowTotal: -332.5000 accountingStandard: US GAAP
equityRatio: 88.1704 debtEquityRatio: 13.4167
liquidityI: 112.2717 liquidityII: 180.3444
netMargin: 29.8524 grossMargin: 69.3245
cashFlowMargin: 36.5913 ebitMargin: 31.8909
ebitdaMargin: 0.0000 preTaxROE: 15.8164
preTaxROA: 13.9454 roe: 14.2626
roa: 12.5754 netIncomeGrowth: 60.7203
revenuesGrowth: 31.0137 taxExpenseRate: 8.5806
equityTurnover: 0.4778 epsBasic: 4.7900
epsDiluted: 4.6600 epsBasicGrowth: 58.6093
incomeBeforeTaxes: 1890.3000 priceEarningsRatioCompany: 75.0104
priceCashFlowRatio: 61.5188 bookValuePerShare: 33.4080
marketCap: 128537430338.3000 earningsYield: 1.3331
pegRatio: 1.2798 cashFlowPerShare: 5.8405
netAssetsPerShare: 33.5488 priceBookValueRatio: 10.7549
priceEarningsRatio: 75.4062 netEarningsPerShare: 4.7649
currency: USD
year: 2022 units: 1000000
balanceSheetTotal: 12974.0000 cash: 1581.2000
currentAssets: 6253.0000 fixedAssets: 6721.0000
liabilities: 1422.1000 totalLiabilitiesEquity: 12974.0000
totalShareholdersEquity: 11112.6000 property: 2374.2000
longTermInvestments: 2623.6000 inventories: 893.2000
accountsReceivable: 942.1000 accountsPayable: 147.0000
liabilitiesTotal: 1861.4000 minorityInterests: 70.7000
sales: 6222.2000 depreciation: 365.8000
netIncome: 1322.3000 operatingResult: 1577.1000
incomeInterest: 29.7000 investments: 879.0000
incomeTaxes: 262.4000 costGoodsSold: 2026.2000
grossProfit: 4196.0000 minorityInterestsProfit: 22.1000
cashFlow: 1490.8000 cashFlowInvesting: 1370.8000
cashFlowFinancing: -2572.3000 cashFlowTotal: 294.7000
accountingStandard: US GAAP equityRatio: 85.6528
debtEquityRatio: 16.7504 liquidityI: 111.1877
liquidityII: 177.4348 netMargin: 21.2513
grossMargin: 67.4360 cashFlowMargin: 23.9594
ebitMargin: 25.3463 ebitdaMargin: 0.0000
preTaxROE: 14.4593 preTaxROA: 12.3848
roe: 11.8991 roa: 10.1919
netIncomeGrowth: -22.4275 revenuesGrowth: 8.9683
taxExpenseRate: 16.3306 equityTurnover: 0.5599
epsBasic: 3.7200 epsDiluted: 3.6500
epsBasicGrowth: -22.3382 incomeBeforeTaxes: 1606.8000
priceEarningsRatioCompany: 71.3306 priceCashFlowRatio: 62.3664
bookValuePerShare: 31.7150 marketCap: 92975901322.6500
earningsYield: 1.4019 pegRatio: -3.1932
cashFlowPerShare: 4.2547 netAssetsPerShare: 31.9168
priceBookValueRatio: 8.3667 priceEarningsRatio: 70.3138
netEarningsPerShare: 3.7738 currency: USD
year: 2023 priceEarningsRatioCompany: 84.0753
priceCashFlowRatio: 73.5094 bookValuePerShare: 31.7150
marketCap: 109590499747.6800 earningsYield: 1.1894
pegRatio: -3.7637 cashFlowPerShare: 4.2547
netAssetsPerShare: 31.7150 priceBookValueRatio: 9.8616
priceEarningsRatio: 82.8767 netEarningsPerShare: 3.7738
currency: USD

Finanzen (ausführlich)

year: 2021
units: 1000000
balanceSheetTotal: 13555.0000
cash: 1290.9000
currentAssets: 5844.9000
fixedAssets: 7710.1000
liabilities: 1149.8000
nonCurrentLiabilities: 453.7000
totalLiabilitiesEquity: 13555.0000
totalShareholdersEquity: 11951.5000
employees: 9793
property: 1876.4000
longTermInvestments: 4415.5000
inventories: 587.1000
accountsReceivable: 782.7000
accountsPayable: 121.2000
liabilitiesTotal: 1603.5000
minorityInterests: 50.4000
sales: 5710.1000
depreciation: 310.2000
netIncome: 1704.6000
operatingResult: 1821.0000
incomeInterest: 69.3000
investments: 671.0000
incomeTaxes: 162.2000
costGoodsSold: 1751.6000
grossProfit: 3958.5000
minorityInterestsProfit: 23.5000
revenuePerEmployee: 583079.7508
cashFlow: 2089.4000
cashFlowInvesting: -2461.5000
cashFlowFinancing: 43.0000
cashFlowTotal: -332.5000
accountingStandard: US GAAP
equityRatio: 88.1704
debtEquityRatio: 13.4167
liquidityI: 112.2717
liquidityII: 180.3444
netMargin: 29.8524
grossMargin: 69.3245
cashFlowMargin: 36.5913
ebitMargin: 31.8909
ebitdaMargin: 0.0000
preTaxROE: 15.8164
preTaxROA: 13.9454
roe: 14.2626
roa: 12.5754
netIncomeGrowth: 60.7203
revenuesGrowth: 31.0137
taxExpenseRate: 8.5806
equityTurnover: 0.4778
epsBasic: 4.7900
epsDiluted: 4.6600
epsBasicGrowth: 58.6093
incomeBeforeTaxes: 1890.3000
priceEarningsRatioCompany: 75.0104
priceCashFlowRatio: 61.5188
bookValuePerShare: 33.4080
marketCap: 128537430338.3000
earningsYield: 1.3331
pegRatio: 1.2798
cashFlowPerShare: 5.8405
netAssetsPerShare: 33.5488
priceBookValueRatio: 10.7549
priceEarningsRatio: 75.4062
netEarningsPerShare: 4.7649
currency: USD
year: 2022
units: 1000000
balanceSheetTotal: 12974.0000
cash: 1581.2000
currentAssets: 6253.0000
fixedAssets: 6721.0000
liabilities: 1422.1000
totalLiabilitiesEquity: 12974.0000
totalShareholdersEquity: 11112.6000
property: 2374.2000
longTermInvestments: 2623.6000
inventories: 893.2000
accountsReceivable: 942.1000
accountsPayable: 147.0000
liabilitiesTotal: 1861.4000
minorityInterests: 70.7000
sales: 6222.2000
depreciation: 365.8000
netIncome: 1322.3000
operatingResult: 1577.1000
incomeInterest: 29.7000
investments: 879.0000
incomeTaxes: 262.4000
costGoodsSold: 2026.2000
grossProfit: 4196.0000
minorityInterestsProfit: 22.1000
cashFlow: 1490.8000
cashFlowInvesting: 1370.8000
cashFlowFinancing: -2572.3000
cashFlowTotal: 294.7000
accountingStandard: US GAAP
equityRatio: 85.6528
debtEquityRatio: 16.7504
liquidityI: 111.1877
liquidityII: 177.4348
netMargin: 21.2513
grossMargin: 67.4360
cashFlowMargin: 23.9594
ebitMargin: 25.3463
ebitdaMargin: 0.0000
preTaxROE: 14.4593
preTaxROA: 12.3848
roe: 11.8991
roa: 10.1919
netIncomeGrowth: -22.4275
revenuesGrowth: 8.9683
taxExpenseRate: 16.3306
equityTurnover: 0.5599
epsBasic: 3.7200
epsDiluted: 3.6500
epsBasicGrowth: -22.3382
incomeBeforeTaxes: 1606.8000
priceEarningsRatioCompany: 71.3306
priceCashFlowRatio: 62.3664
bookValuePerShare: 31.7150
marketCap: 92975901322.6500
earningsYield: 1.4019
pegRatio: -3.1932
cashFlowPerShare: 4.2547
netAssetsPerShare: 31.9168
priceBookValueRatio: 8.3667
priceEarningsRatio: 70.3138
netEarningsPerShare: 3.7738
currency: USD
year: 2023
priceEarningsRatioCompany: 84.0753
priceCashFlowRatio: 73.5094
bookValuePerShare: 31.7150
marketCap: 109590499747.6800
earningsYield: 1.1894
pegRatio: -3.7637
cashFlowPerShare: 4.2547
netAssetsPerShare: 31.7150
priceBookValueRatio: 9.8616
priceEarningsRatio: 82.8767
netEarningsPerShare: 3.7738
currency: USD